New therapeutic key for cystic fibrosis: a role for lipoxins
New therapeutic key for cystic fibrosis: a role for lipoxins
复制标题
DOI:
10.1038/ni0404-357
复制
发表时间:
2004-04
影响因子:
30.5
通讯作者:
D. Takai;T. Nagase;Takao Shimizu
中科院分区:
文献类型:
--
作者:
D. Takai;T. Nagase;Takao Shimizu
One of the hallmarks of cystic fibrosis is the propensity of patients to develop lung infections withPseudomonas aeruginosa, which eventually compromises lung function. New data suggest loss of CFTR impairs lipoxin production, thus preventing resolution of lung inflammation and creating an environment susceptible to further infection.